{{Rsnum
|rsid=222016
|Gene=GC
|Chromosome=4
|position=71769258
|Orientation=plus
|GMAF=0.3246
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GC
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 68.8 | 29.5 | 1.8
| HCB | 42.6 | 40.4 | 16.9
| JPT | 47.8 | 39.8 | 12.4
| YRI | 12.9 | 51.7 | 35.4
| ASW | 21.1 | 50.9 | 28.1
| CHB | 42.6 | 40.4 | 16.9
| CHD | 38.5 | 45.0 | 16.5
| GIH | 81.2 | 17.8 | 1.0
| LWK | 8.2 | 40.9 | 50.9
| MEX | 53.4 | 41.4 | 5.2
| MKK | 19.2 | 56.4 | 24.4
| TSI | 70.6 | 27.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21844150
|Title=Associations of Vitamin D Binding Protein Gene Polymorphisms with the Development of Peripheral Arthritis and Uveitis in Ankylosing Spondylitis
}}

{{PMID Auto
|PMID=19255064
|Title=Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=23456391
|Title=Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}